283 related articles for article (PubMed ID: 32856112)
21. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.
Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF
BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680
[TBL] [Abstract][Full Text] [Related]
22. High expression of HNRNPR in ESCA combined with
Liu XY; Gao Y; Kui XY; Liu XS; Zhang YH; Zhang Y; Ke CB; Pei ZJ
J Transl Med; 2022 Oct; 20(1):450. PubMed ID: 36195940
[TBL] [Abstract][Full Text] [Related]
23. 18F-FDG PET/CT and circulating tumor cells in treatment-naive patients with non-small-cell lung cancer.
Zhang F; Wu X; Zhu J; Huang Y; Song X; Jiang L
Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3250-3259. PubMed ID: 33630146
[TBL] [Abstract][Full Text] [Related]
24. The clinical value of texture analysis of dual-time-point
Nakajo M; Jinguji M; Aoki M; Tani A; Sato M; Yoshiura T
Eur Radiol; 2020 Mar; 30(3):1759-1769. PubMed ID: 31728684
[TBL] [Abstract][Full Text] [Related]
25. Correlation between
Guo F; Li X; Yao G; Zeng G; Yu L
PeerJ; 2019; 7():e7635. PubMed ID: 31565568
[TBL] [Abstract][Full Text] [Related]
26. Predictive value of CT and
Li H; Li L; Liu Y; Deng Y; Zhu Y; Huang L; Long T; Zeng L; Shu Y; Peng D
BMC Cancer; 2024 Apr; 24(1):434. PubMed ID: 38589832
[TBL] [Abstract][Full Text] [Related]
27. Associations of volumetric whole-body
Araç E; Can C; Kömek H
Hell J Nucl Med; 2020; 23(1):40-47. PubMed ID: 32361716
[TBL] [Abstract][Full Text] [Related]
28. Correlation study on 18F-FDG PET/CT metabolic characteristics of primary lesion with clinical stage in lung cancer.
Hu WD; Wang HC; Wang YB; Cui LL; Chen XH
Q J Nucl Med Mol Imaging; 2021 Jun; 65(2):172-177. PubMed ID: 30916535
[TBL] [Abstract][Full Text] [Related]
29. [The correlation between metabolic parameters in (18)F-FDG PET-CT and solid and micropapillary histological subtypes in lung adenocarcinoma].
Guo Y; Yao ZM; Chen M; Chen CX
Zhonghua Zhong Liu Za Zhi; 2022 Jun; 44(6):555-561. PubMed ID: 35754230
[No Abstract] [Full Text] [Related]
30. Prognostic significance of volume-based 18F-FDG PET/CT parameters and correlation with PD-L1 expression in patients with surgically resected lung adenocarcinoma.
Wang D; Li Y; Chen X; Li P
Medicine (Baltimore); 2021 Sep; 100(35):e27100. PubMed ID: 34477147
[TBL] [Abstract][Full Text] [Related]
31. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma].
Ding CY; Guo Z; Sun J; Yang WP; Li TR
Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):528-533. PubMed ID: 30060362
[No Abstract] [Full Text] [Related]
32. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer.
Lee JW; Kang CM; Choi HJ; Lee WJ; Song SY; Lee JH; Lee JD
J Nucl Med; 2014 Jun; 55(6):898-904. PubMed ID: 24711649
[TBL] [Abstract][Full Text] [Related]
33. Utility of Volumetric Metabolic Parameters on Preoperative FDG PET/CT for Predicting Tumor Lymphovascular Invasion in Non-Small Cell Lung Cancer.
Li C; Tian Y; Shen Y; Wen B; He Y
AJR Am J Roentgenol; 2021 Dec; 217(6):1433-1443. PubMed ID: 33978465
[No Abstract] [Full Text] [Related]
34. [
Annovazzi A; Ferraresi V; Anelli V; Covello R; Vari S; Zoccali C; Biagini R; Sciuto R
Eur Radiol; 2021 Sep; 31(9):7012-7021. PubMed ID: 33715090
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of metabolic tumor volume and total lesion glycolysis from ¹⁸F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma.
Liu DD; Li J; Li X; Xie L; Qin L; Peng F; Cheng MH
J Gynecol Oncol; 2019 Nov; 30(6):e89. PubMed ID: 31576685
[TBL] [Abstract][Full Text] [Related]
36. Improving the imaging diagnostic strategy for pulmonary artery masses based on
Hong C; Hou P; Chen HM; Zhong KX; Guo WL; Lin JL; Wu XF; Lei YX; Jia Q; Liu CL; Li SY; Wang XL
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4109-4121. PubMed ID: 35732973
[TBL] [Abstract][Full Text] [Related]
37. [The relationship between (18)F-FDG PET/CT metabolic parameters and clinicopathological features of breast cancer].
Tang B; Zhang Y; Zhou J; Xu Y; Li TR; Ding CY
Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):280-285. PubMed ID: 28550668
[No Abstract] [Full Text] [Related]
38. Prognostic value of metabolic tumour volume and total lesion glycolysis in
Jiménez-Ballvé A; García García-Esquinas M; Salsidua-Arroyo O; Serrano-Palacio A; García-Sáenz JA; Ortega Candil A; Fuentes Ferrer ME; Rodríguez Rey C; Román-Santamaría JM; Moreno F; Carreras-Delgado JL
Rev Esp Med Nucl Imagen Mol; 2016; 35(6):365-372. PubMed ID: 26948652
[TBL] [Abstract][Full Text] [Related]
39. SFXN1 as a potential diagnostic and prognostic biomarker of LUAD is associated with
Zhang YH; Liu XS; Gao Y; Yuan LL; Huang ZM; Zhang Y; Liu ZY; Yang Y; Liu XY; Ke CB; Pei ZJ
Lung Cancer; 2024 Feb; 188():107449. PubMed ID: 38184958
[TBL] [Abstract][Full Text] [Related]
40. Usefulness of 18 F-FDG PET/computed tomography metabolic parameters in predicting sarcopenia and prognosis of treatment-naive patients with non-small cell lung cancer.
Li D; Tan X; Yuan H; Yao X; Sun X; He L; Jiang L
Nucl Med Commun; 2023 Apr; 44(4):309-317. PubMed ID: 36756769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
